NEWS
12. July 2010
>RELDATA Named Tech Awards Circle Winner / Unified Block and File Storage Solutions Provider Selected ...
18. June 2010
>RELDATA Selected as AlwaysOn East Top 100 Winner for Cloud and Infrastructure Technology Unified Storage ...
7. June 2010
>On June 24, 2010, the 8th annual Grazia Equity Business Plan Competition was hosted at ...
5. June 2010
>immatics announces Phase II Results with its Therapeutic Cancer Vaccine IMA901 in Patients with Advanced ...
2. June 2010
>Online-Brillenhändler Mister Spex zählt zu "Red Herring 100 Europe" Unternehmen Red Herring Europe Award ...
2. June 2010
>immatics enters Collaboration with the National Cancer Institute (NCI) to Advance the Development of IMA950 ...
16. February 2010
>immatics Enters Collaboration with Cancer Research UK to Develop Multi-target Rationally Designed Therapeutic Cancer Vaccine ...
4. February 2010
>XConnect revenue doubled in 2009 XConnect, the leader in next-generation interconnection and carrier ENUM-registry ...
1. February 2010
>Online-Brillenhändler Mister Spex hat 2009 Brillen und Kontaktlinsen für rund 4,5 Millionen Euro verkauft – ...
26. January 2010
>RELDATA UNIFIED STORAGE NAMED ONE OF “100 COOLEST CLOUD COMPUTING PRODUCTS” BY EVERYTHING CHANNEL’S CRN ...
20. January 2010
>RELDATA (www.reldata.com), a provider of software-centric unified storage solutions, announced today its new RELDATA Partner ...
14. January 2010
>HORIZONT und Statista starten Portal HORIZONTstats.de Premium-Initiative für Paid Content Auf HORIZONTstats.de gibt es ...
9. December 2009
>First Chip Supplier to Offer 4x4 MIMO Wi-Fi Devices Will Play Active Role in One ...
2. December 2009
>Conergy Solar Factory in Frankfurt (Oder): Three Years "Quality Made in Germany" Ramp ...
20. November 2009
>Investoren-Einstieg unterstützt weitere Wachstumsstrategie Der Stuttgarter Finanzinvestor Grazia Equity ist beim After Sales Dienstleister ...
16. November 2009
>Allzu viele Partner bei der Finanzierung können das Wachstum eines jungen Unternehmens stören. Es kommt ...
22. October 2009
>COPRO will sich mit allen Projekten in der virtuellen Welt Twinity präsentieren. Als erstes ...
19. October 2009
>Mit Mister Spex bringt Dirk Graber den Durchblick zurück. Wir haben ihn zu seiner Arbeit ...
5. October 2009
>Statistik-Portal startet heute sein Premium-Angebot, das für 29,90 Euro pro Monat die Verwendung exklusiver Daten ...
1. October 2009
>"Gründerszene ist sehr unterentwickelt" Von Claus G. Schmalholz Lothar Späth, zuletzt Vorsitzender der ...
29. September 2009
>immatics biotechnologies GmbH today announced the appointment of Dr Carsten Reinhardt as Chief Medical Officer ...
22. September 2009
>RELDATA Introduces Next Generation 9240i Unified Storage System Powered by Enhanced RELvos 2.4 Virtualization OS ...
16. September 2009
>Venture capital firms Venrock Associates, Accel Partners, Grazia Equity and Crescent Point Group all participated ...
9. September 2009
>Nanosolar Completes Panel Factory, Commences Serial Production Today Nanosolar demonstrated the completion of its ...
9. September 2009
>Nanosolar Unveils Nanosolar Utility Panel™ Technology In conjunction with today's inauguration of our panel-assembly ...
9. September 2009
>NREL Certifies 16.4% Nanosolar Foil Efficiency It was May 2006 when we last released ...
10. August 2009
>immatics biotechnologies GmbH today announced that the company obtained European patent protection for the composition ...
7. August 2009
>How creativity is helping the German capital cope with economic crisis. BERLIN — The ...
27. July 2009
>Portal will Informationen für Marketingentscheider bündeln Mit einem neuen Seitenkonzept will das Statistik-Portal „Statista“ ...
21. July 2009
>RELDATA Named a CRN Emerging Technology Vendor RELDATA's unified storage solutions provide channel partners ...
7. July 2009
>Ehemaliger Ministerpräsident arbeitet für Venture Capital-Geber: Lothar Späth berät Grazia Equity Prof. Dr. h.c. ...
7. July 2009
>Metaversum GmbH, developer of Twinity, the world’s first mirror world – a virtual world made ...
3. July 2009
>Grazia Equity Award für die beste Geschäftsidee an der HHL Von einer Charityplattform ...
30. June 2009
>Conergy sells solar portfolio with a capacity of 10.7 MWp ...
17. June 2009
>immatics biotechnologies significantly improves XPRESIDENT™ technology platform. immatics biotechnologies today announced the completion of ...
10. June 2009
>Australia: Planning Approval for 282 Wind Turbines EPURON reaches key milestone for the largest ...
8. June 2009
>Conergy Deutschland GmbH sells the Heimpersdorf megawatt solar park to investor Conergy Deutschland GmbH ...
5. June 2009
>Die zweite Auflage des Buches "IT-Governance in der Praxis" von den Autoren Andreas Rüter (Grazia ...
29. May 2009
>moviepilot.de: Führender personalisierbarer Entertainmentguide für Kino, DVD und TV schließt zweite Finanzierungsrunde ab Berlin, 29.05.2009 ...
19. May 2009
>Solarstrom von Conergy reduziert Kosten für Wasserversorgung in Kalifornien • 1,6 MWp Solarpark im ...
14. May 2009
>Statista startet Geschäftskunden-Angebot Statistik-Portal bietet umfassende Markenreports und kostengünstige Online-Umfragen Ausführliche Analysen zu ...
8. May 2009
>Solar energy from the region, for the region: Conergy Deutschland inaugurates a megawatt class thin-film ...
28. April 2009
>XCONNECT NAMES RICHARD SHOCKEY, ENUM PIONEER AND IP COMMUNICATIONS EXPERT, TO ADVISORY BOARD Appointment ...
27. April 2009
>RELDATA EXPANDS ITS SALES ORGANIZATION Industry Veteran Peter Cmaylo joins RELDATA as VP Sales ...
22. April 2009
>XCONNECT EXPANDS GLOBAL ALLIANCE FEDERATION SERVICES Innovations Bring Communications Service Providers More NGN ...
20. April 2009
>Must-have-Accessoires: Hält die Brille mit der It-Bag Schritt? Das Mister Spex "Brillen-Mode-Barometer" analysiert ...
8. April 2009
>Metaversum and Twinity has been elected a Red Herring 100 Europe Winner 2009 With ...
24. March 2009
>OVERGENCE SESSION MANAGER LATEST VOIP-PEERABLE DEVICE CERTIFIED XCONNECT-READY Testing for ENUM Query Compatibility Streamlines ...
2. March 2009
>immatics completes patient recruitment in phase II study with cancer vaccine IMA901 for renal cell ...
24. February 2009
>Quantenna Raises $15 Million in Series D Financing Round Quantenna Communications, Inc., a leader ...
24. February 2009
>RELDATA AND XYRATEX ENABLE HETEROGENEOUS STORAGE RELDATA 9240 and Xyratex F6412E RAID system certification ...
26. January 2009
>immatics wins 29th German Industry’s Innovation Award (Innovationspreis der deutschen Wirtschaft) Tuebingen, January 26, ...
26. January 2009
>The Growing Market for Solar Cells Printing is playing a key role in ...
24. January 2009
>VC Investing Drops For 2008, But Green Grows Venture capital investment shrank in 2008 ...
21. October 2008
>Metaversum Awarded Funding in Co-space™ program in Singapore Metaversum, developer and operator of ...
5. September 2008
>Wowereit Opens Virtual Berlin in Twinity Metaversum GmbH, developer and operator of the ...
17. June 2009
XPRESIDENTâ„¢ technology platform
immatics biotechnologies significantly improves XPRESIDENT™ technology platform.
immatics biotechnologies today announced the completion of the next generation of its proprietary antigen discovery engine XPRESIDENT™. This significant step forward in immatics’ core technology platform allows for the first time the direct quantification of tumor-associated peptides (TUMAPs) presented on the surface of tumor cells in comparison to peptides presented on healthy tissues. This will enable the identification of new antigens and novel targets which cannot be discovered by classical genomics and proteomics approaches.
XPRESIDENT™ combines mass spectrometry, genomics, biochemistry, and immunology and has already generated a range of cancer vaccine products in clinical (IMA901, IMA910) and preclinical development (IMA950). The platform has been developed and continuously improved since 2002, when it was first introduced by Toni Weinschenk, co-founder and Head of Discovery at immatics. Since then, the capacity of the platform has been expanded by factor of more than 10 and the sensitivity has reached the femtomolar level. The new direct quantification capacity is providing immatics with an additional important feature to speed up antigen and peptide identification and selection. As a result, the Company‘s discovery engine is generating validated candidates for further clinical development across a broad range of cancer indications at an unprecedented speed.
„With the improved XPRESIDENT™ version we will be able to identify completely novel antigens independent of conventional approaches such as genomics and proteomics. This is a significant step forward in our drug discovery abilities.“, said Harpreet Singh, Chief Scientific Officer of immatics.
„The completion of the new version of our XPRESIDENT™ technology platform further increases and refines our ability to identify tumour-specific antigens and peptides. Both immatics and partner companies will be able to use this insight to develop more specific and targeted cancer immunotherapies.“ added Paul Higham, Chief Executive Officer of immatics.
Moreover, the immunomonitoring capabilities of the company have significantly increased. In the last two years, a state-of-the art immunomonitoring facility has been set up allowing the central and highly standardized assessment of immune responses of patients treated with cancer vaccines from all over Europe. This facility will also enable the delivery of extensive immunomonitoring and biomarker data for mid- and late-stage clinical trials.
About XPRESIDENT™
The unique feature of the XPRESIDENT™ Discovery engine is its high sensitivity (down to femtomolar range) allowing the identification of TUMAPs directly from surgically removed primary cancer tissue. Thus, TUMAPs identified by XPRESIDENT™ are confirmed to be naturally presented by real human tumors. This is a significant advantage over using human cell lines as source material which often differ significantly from primary tumor cells in their respective pattern of antigen expression, processing and presentation.
For further information please contact media@immatics.com.